10 Large-Cap Stocks Insiders Are Selling Recently

2. Tempus AI, Inc. (NASDAQ:TEM)

Number of Insiders Selling: 11

Market Capitalization: $10.857B

Tempus AI is a health technology company founded in 2015. The company is focused on integrating artificial intelligence and machine learning to advance precision medicine. Tempus AI is behind one of the world’s largest libraries of clinical and molecular data and an operating system that makes that data accessible and useful.

Over the last 12 months, 11 insiders sold some of their Tempus AI shares. Collectively, insiders among which are the company’s CEO and CFO sold a total of around $278.71 million worth of shares at an average price of $43.65 per share. Since the beginning of the year, Tempus shares went up 112.06%, and are now trading at $71.60 per share.

In February, the company announced it has completed its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Tempus AI paid $375 million in cash and $225 million in shares at closing, of which $100 million is subject to a lock-up agreement until one year post-transaction close.

For the full year 2024, the company reported revenue of $693 million, representing approximately 30% growth year-over-year.

As per 11 analysts, the average rating for Tempus AI is “Buy,” and the 12-month stock price target is $50.6, which is a decrease of 16.23% from the latest price.

Since the company went public in June 2024, its shares gained 80.22%.